Stryker Corporation income statement

In fiscal 2025, Stryker Corporation reported revenue of $25.12bn, up 11.2% on the year before, operating income of $4.89bn (a 19.5% margin) and net income of $3.25bn, or $8.40 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Stryker Corporation: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	6.7	7.3	8.3	8.7	9.0	9.7	9.9	11.3	12.4	13.6	14.9	14.4	17.1	18.4	20.5	22.6	25.1	26.3
Cost of revenue	—	—	—	—	—	—	—	3.8	4.3	4.7	5.2	5.3	6.1	6.9	7.4	8.2	9.1	9.1
Gross profit	4.5	5.0	5.5	5.9	6.0	6.4	6.6	7.5	8.2	8.9	9.7	9.1	11.0	11.6	13.1	14.4	16.1	17.2
Research and development	0.3	0.4	0.5	0.5	0.5	0.6	0.6	0.7	0.8	0.9	1.0	1.0	1.2	1.5	1.4	1.5	1.6	1.7
Selling, general and administrative	2.5	2.7	3.2	3.4	3.5	3.5	3.6	4.1	4.6	5.1	5.4	5.4	6.4	6.4	7.1	7.7	8.7	9.1
Operating income	1.6	1.8	1.7	1.7	1.3	1.2	1.9	2.2	2.3	2.5	2.7	2.2	2.6	2.8	3.9	3.7	4.9	5.4
Interest expense	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.4	0.4	0.6	0.6
Income before tax	1.6	1.7	1.7	1.7	1.2	1.2	1.7	1.9	2.1	2.4	2.6	2.0	2.3	2.7	3.7	3.5	4.5	5.1
Income tax	0.5	0.5	0.3	0.4	0.2	0.6	0.3	0.3	1.0	−1.2	0.5	0.4	0.3	0.3	0.5	0.5	1.3	1.5
Net income	1.1	1.3	1.3	1.3	1.0	0.5	1.4	1.6	1.0	3.6	2.1	1.6	2.0	2.4	3.2	3.0	3.2	3.6
Diluted EPS	$2.77	$3.19	$3.45	$3.39	$2.63	$1.34	$3.78	$4.35	$2.68	$9.34	$5.48	$4.20	$5.21	$6.17	$8.25	$7.76	$8.40	$9.39
Diluted shares (average)	399m	400m	390m	383m	382m	383m	381m	379m	380m	380m	380m	380m	382m	382m	384m	386m	387m	386m
EBITDA	2.0	2.2	2.2	2.2	1.8	1.8	2.5	2.9	3.2	3.5	3.8	3.3	3.9	4.1	5.2	5.1	6.5	7.0

US$ millions unless shown otherwise. Fiscal quarters.

Stryker Corporation: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	6,436	5,866	6,022	6,057	7,171	6,020	6,589	6,520
Cost of revenue	2,262	2,122	2,181	2,205	2,543	2,210	2,091	2,272
Gross profit	4,174	3,744	3,841	3,852	4,628	3,810	4,498	4,248
Research and development	358	405	407	410	401	413	434	433
Selling, general and administrative	2,123	2,300	2,079	2,045	2,227	2,281	2,229	2,313
Operating income	581	837	1,113	1,135	1,804	936	1,659	1,034
Interest expense	117	137	159	157	154	148	141	143
Income before tax	528	764	1,016	1,029	1,705	850	1,564	997
Income tax	−18	110	132	170	856	105	288	244
Net income	546	654	884	859	849	745	1,276	753
Diluted EPS	$1.41	$1.69	$2.29	$2.22	$2.20	$1.93	$3.30	$1.96
EBITDA	927	1,198	1,500	1,537	2,221	1,333	2,063	1,431

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: GEHC vs SYK BSX vs SYK PHG vs SYK MDT vs SYK

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Stryker Corporation's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Stryker Corporation.